Cryosite Limited (ASX:CTE)
Australia · Delayed Price · Currency is AUD 1.170
-0.010 (-0.85%)
Sep 17, 2026, 4:10 PM AEST
Cryosite Market Cap
Cryosite has a market cap or net worth of 57.6 million as of September 16, 2026. Its market cap has increased by 37.21% in one year.
Market Cap
57.60M
Enterprise Value
63.07M
Revenue
16.70M
Ranking
n/a
PE Ratio
27.19
Stock Price
1.17
ChartMarket Cap Chart
Since May 9, 2002, Cryosite's market cap has increased from 18.00 to 57.60M, an increase of 319,973,700.00%. That is a compound annual growth rate of 84.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 57.11M | 17.00% |
| Dec 29, 2025 | 48.81M | 17.65% |
| Dec 27, 2024 | 41.49M | 40.50% |
| Dec 29, 2023 | 29.53M | -17.12% |
| Dec 30, 2022 | 35.63M | 56.99% |
| Dec 31, 2021 | 22.70M | 22.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 505.18M |
| Healius | 308.62M |
| Monash IVF Group | 305.86M |
| Microba Life Sciences | 38.72M |
| Rhythm Biosciences | 29.02M |
| BCAL Diagnostics | 26.18M |
| INOVIQ | 23.93M |
| Genetic Signatures | 18.40M |